Biocon Ltd. (BIOCON) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 201791, "name": "Biocon", "stock_name": "Biocon", "full_name": "Biocon Ltd.", "name_url": "stocks-analysis/biocon", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "380.75", "chg": 11.85, "chgp": "3.21%", "dir": 1, "prev_price": "368.90", "mcapval": "60,654.00 Cr", "mcap": "Mid Cap", "scripcode": 532523, "symbol": "BIOCON", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE376G01013", "curr_date": "May 06", "curr_time": "", "bse_nse_vol": "65.16 lacs", "exc_status": "Active", "traded_date": "May 06, 2026", "traded_date_str": "2026 05 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biocon-201791-0&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "HT", "url": "https://www.marketsmojo.com/mojopro/strategy/1", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biocon-201791-0&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Biocon Ltd. is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-ltd-is-rated-sell-by-marketsmojo-3977507", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BioconLtd_mojoScore_3977507.png", "date": "2026-05-06 10:10:40", "description": "Biocon Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Biocon Ltd. Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-technical-momentum-shifts-amid-mixed-market-signals-3974601", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BioconLtd_technicaldot_3974601.png", "date": "2026-05-05 08:00:43", "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a modest day change of 0.24% to close at ₹360.40, the stock’s technical indicators present a complex picture, with some signals suggesting caution while others hint at potential stabilisation. This article analyses the recent technical parameter changes, key momentum indicators, and the stock’s performance relative to the broader market." }, { "title": "Biocon Ltd. Technical Momentum Shifts Signal Bearish Outlook Amid Mixed Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-technical-momentum-shifts-signal-bearish-outlook-amid-mixed-market-returns-3973393", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BioconLtd_technicaldot_3973393.png", "date": "2026-05-04 08:00:17", "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, which collectively signal a cautious outlook for investors amid mixed signals and recent price movements." }, { "title": "Biocon Ltd Gains 2.83%: Key Technical and Derivatives Activity Shape Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-gains-283-key-technical-and-derivatives-activity-shape-week-3971934", "imagepath": "", "date": "2026-05-03 14:00:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Apr:</strong> Stock surged 3.47% on strong volume and Sensex gains</p>\n <p><strong>29 Apr:</strong> Sharp 36.05% rise in derivatives open interest amid mixed technical signals</p>\n <p><strong>30 Apr:</strong> Price slipped 0.76% as technical momentum showed mild bearishness</p>\n <p><strong>01 May:</strong> No trading data available; week closed at Rs.359.55</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.349.65</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week C..." }, { "title": "Biocon Ltd. Sees Sharp Surge in Derivatives Open Interest Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-sharp-surge-in-derivatives-open-interest-amid-mixed-market-signals-3968498", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BioconLtd_oi_spurts_by_underlying_3968498.png", "date": "2026-04-29 15:00:07", "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 36.05% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest price gain of 0.14% on 29 Apr 2026, the stock underperformed its sector by 0.36% and the broader Sensex by 0.81%, reflecting a complex interplay between bullish bets and cautious sentiment." }, { "title": "Biocon Ltd. Sees Sharp Surge in Open Interest Amidst Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-sharp-surge-in-open-interest-amidst-mixed-market-signals-3968435", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BioconLtd_oi_spurts_by_underlying_3968435.png", "date": "2026-04-29 14:00:06", "description": "Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 34.25% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 0.17% price gain today, the stock’s recent volume and delivery data suggest a complex interplay of bullish and cautious sentiment among traders." }, { "title": "Biocon Ltd Sees Sharp Open Interest Surge Amid Rising Investor Activity", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-sharp-open-interest-surge-amid-rising-investor-activity-3968397", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BioconLtd_oi_spurts_by_underlying_3968397.png", "date": "2026-04-29 13:00:06", "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes alongside a steady price appreciation and increased delivery volumes, suggesting a nuanced directional bet by market participants." }, { "title": "Biocon Ltd Sees Sharp Open Interest Surge Amid Rising Investor Participation", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-sharp-open-interest-surge-amid-rising-investor-participation-3968359", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BioconLtd_oi_spurts_by_underlying_3968359.png", "date": "2026-04-29 12:00:05", "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. The stock’s recent performance, combined with increased delivery volumes and a notable rise in futures and options activity, suggests evolving directional bets among traders and investors alike." }, { "title": "Biocon Ltd Sees Sharp Open Interest Surge Amid Rising Investor Activity", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-sharp-open-interest-surge-amid-rising-investor-activity-3968279", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BioconLtd_oi_spurts_by_underlying_3968279.png", "date": "2026-04-29 11:00:05", "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. The stock has outperformed its sector peers with a 1.01% gain today, supported by a 21.9% increase in open interest and rising delivery volumes, reflecting growing investor conviction amid mixed technical signals." } ], "total": 5817, "sid": "201791", "stock_news_url": "https://www.marketsmojo.com/news/biocon-201791" }, "announcements": [ { "caption": "Update on board meeting", "datetime": "04-May-2026", "details": "Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 inter alia to consider and approve Update on prior intimation of Board meeting to be held on May 07 2026", "source": "BSE" }, { "caption": "Company Statement", "datetime": "30-Apr-2026", "details": "Company Statement", "source": "BSE" }, { "caption": "Certificate Pursuant To SEBI Master Circular No. SEBI/HO/DDHS/DDHS-Pod/P/CIR/2025/0000000137 Dated October 15 2025", "datetime": "29-Apr-2026", "details": "Certificate pursuant to SEBI Master Circular dated October 15 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "07 May 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Biocon Ltd. has declared <strong>10%</strong> dividend, ex-date: 04 Jul 25", "dt": "2025-07-04", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Biocon Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 12 Jun 19", "dt": "2019-06-12", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Apr: Stock surged 3.47% on strong volume and Sensex gains

29 Apr: Sharp 36.05% rise in derivatives open interest amid mixed technical signals

30 Apr: Price slipped 0.76% as technical momentum showed mild bearishness

01 May: No trading data available; week closed at Rs.359.55

Week Open

Rs.349.65

Week C...

Read full news article

Biocon Ltd. Sees Sharp Surge in Derivatives Open Interest Amid Mixed Market Signals

2026-04-29 15:00:07

Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 36.05% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest price gain of 0.14% on 29 Apr 2026, the stock underperformed its sector by 0.36% and the broader Sensex by 0.81%, reflecting a complex interplay between bullish bets and cautious sentiment.

Read full news article

Biocon Ltd. Sees Sharp Surge in Open Interest Amidst Mixed Market Signals

2026-04-29 14:00:06

Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 34.25% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 0.17% price gain today, the stock’s recent volume and delivery data suggest a complex interplay of bullish and cautious sentiment among traders.

Read full news article

Biocon Ltd Sees Sharp Open Interest Surge Amid Rising Investor Activity

2026-04-29 13:00:06

Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes alongside a steady price appreciation and increased delivery volumes, suggesting a nuanced directional bet by market participants.

Read full news article

Biocon Ltd Sees Sharp Open Interest Surge Amid Rising Investor Participation

2026-04-29 12:00:05

Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. The stock’s recent performance, combined with increased delivery volumes and a notable rise in futures and options activity, suggests evolving directional bets among traders and investors alike.

Read full news article

Biocon Ltd Sees Sharp Open Interest Surge Amid Rising Investor Activity

2026-04-29 11:00:05

Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. The stock has outperformed its sector peers with a 1.01% gain today, supported by a 21.9% increase in open interest and rising delivery volumes, reflecting growing investor conviction amid mixed technical signals.

Read full news article